Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ASAHI KASEI PHARMA CORPORATION

Home Clinical Trial Sponsors and OrganizationsASAHI KASEI PHARMA CORPORATION

ASAHI KASEI PHARMA CORPORATION

2-1, SAMEJIMA, Fuji, Shizuoka, Japanwww.asahikasei-pharma.co.jp

Also known as:

旭化成制药株式会社

旭化成ファーマ株式会社

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

48

10 active

Approvals

15

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

12

25.0%

Phase 2

10

20.8%

Phase 1

3

6.3%

Phase 4

3

6.3%

Not Applicable

2

4.2%

Trial Status Distribution

Active, not recruiting

10

20.8%

Completed

28

58.3%

Recruiting

3

6.3%

Terminated

1

2.1%

Clinical Trials

Trials sponsored by this organization (48)

A Phase 1 Study of Apraglutide (Single Dose Study)

Mar 202336 participants

Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

Aug 2022200 participants

Follow ups of patients in AK1830 Phase II Studies

Feb 202210 participants

Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)

Feb 202140 participants

Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)

Feb 202120 participants

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

Nov 202030 participants

Clinical study to evaluate the Bordetella pertussis antigen kit for patients suspected to be infected with Bordetella pertussis

Oct 2020203 participants

Randomized, Double-Blind Study of AK1830 in Patients with low back pai

Aug 2020400 participants

Page 1 of 6

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

15

Approvals

Recent Approvals

Naftopidil Tablets

Naftopidil Tablets

Fasudil Hydrochloride Injection

Mizoribine Tablets

Mizoribine Tablets

Isepamicin Sulfate Injection

Isepamicin Sulfate Injection

Elcatonin Injection

Elcatonin Injection

Naftopidil Tablets

News

No news articles found

On this page

Overview
Clinical Trials48
Approvals15
News

Back to Organizations